First published at 02:10 UTC on April 20th, 2024.
MORE
Video clip taken from TNT Radio - 2024.04.18 of Dr. William Makis with The Freeman Report with James Freeman
Dr. Makis' Substack: https://substack.com/@makismd
https://makismd.substack.com/
Source of the full video: https://tntradio.live/shows/the-freeman-report-with-james-freeman/
Study Finds ‘Significant Increase’ in Cancer Mortality After Mass Vaccination With 3rd COVID Dose -
By Megan Redshaw, J.D.
4/19/2024
Epoch Times:
Researchers observed “statistically significant increases” in mortality rates of all cancers, especially estrogen-related cancers, following mass vaccination with the third mRNA COVID-19 vaccine, according to a recent paper.
The study, published on April 8 in Cureus, evaluated the impact of the COVID-19 pandemic on age-adjusted mortality rates for 20 different types of cancer in Japan using official statistics on death, SARS-CoV-2 infections, and vaccination rates. The researchers made a startling discovery: There were no excess cancer deaths in Japan during the first year of the pandemic, but they observed a rise in cancer mortality coinciding with mass vaccination.
Japan has the highest vaccination rates, and is now conducting mass vaccinations with a seventh vaccine dose. According to the researchers, after mass vaccination began in 2021, there was a noticeable increase in cancer mortalities coinciding with the first and second COVID-19 vaccine doses.
Following vaccination with a third mRNA vaccine dose in 2022, researchers observed “significant excess mortalities” for all cancers and specifically estrogen and estrogen receptor alpha (ERα)-sensitive cancers, including ovarian, leukemia, prostrate, lip/oral/pharyngeal, pancreatic, and breast cancers. Notably, breast cancer had a “significant deficit mortality” in 2020 but shifted to excess mortality in 2022 following the rollout of the third vaccine dose.
Source: https://www.theepochtimes.com/health/significant-increase-in-cancer-mortality-after-mass-vaccination-with-3rd-covid-dose-study-5630488
LESS